|
If
you are interested in participating in the following trial, please contact
the relevant Trial Chairperson or Trial Centre Data Manager.
Date first patient entered: 3 March 2004
Target Accrual: 300
Hypothesis: That peak and
overall skin reactions may be reduced by Cavilon Durable Barrier Cream
(CDBC) compared to Sorbolene.
Trial Contacts:
TROG Trial Chairperson
Dr Peter Graham
Cancer Care Centre
St George Hospital
Kogarah NSW 2217
Fax: +612 9350 3958
Trial Centre Data Manager
Cavilon Breast Trial Data Manager
Clinical Trials Unit
Cancer Care Centre
St George Hospital
Fax 02 9350 2960
More Information
[ Open
Trials - Home ]

|